Cargando…

Modeling sepsis using neural nets and biomarkers of organ dysfunction in patients, with links to animal models

Detalles Bibliográficos
Autores principales:	Schentag, J, Parish, D, Opal, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504802/ http://dx.doi.org/10.1186/cc11688

Ejemplares similares

A sepsis progression model in humans: characterization of biomarkers descriptive of sepsis progression
por: Footer, BW, et al.
Publicado: (2011)

Predicting organ failure at 24 hours from early clinical data in an ovine pneumonia-sepsis model
por: Footer, BW, et al.
Publicado: (2010)

Estimating coagulopathy in an ovine acute lung injury model of sepsis using a disease progression model
por: Footer, BW, et al.
Publicado: (2010)

Use of a screening authorization and randomization center for severe sepsis patient qualification and real-time enrollment in a phase 2 trial of eritoran tetrasodium (E5564), a TLR4 antagonist
por: Schentag, J, et al.
Publicado: (2009)

Modeling sepsis induced by methicillin-resistant Staphylococcus aureus infection: a human/ovine approach
por: Schentag, JJ, et al.
Publicado: (2010)

Test characteristics of acute kidney injury biomarkers in animal models of sepsis
por: Peng, Z, et al.
Publicado: (2014)

The importance of antibiotics in animal models of sepsis
por: Maybauer, MO, et al.
Publicado: (2005)

Sepsis and multiple organ dysfunction in burn
por: Henrich, Sabrina F, et al.
Publicado: (2013)

Honey as an immunomodulator during sepsis in animal model
por: Kassim, M, et al.
Publicado: (2009)

The evolution and therapy aspects in multiple organ dysfunction sepsis
por: Bejan, Codrina, et al.
Publicado: (2013)

AB103, a CD28 antagonist peptide: a new therapeutic agent in a model of severe sepsis
por: Teleman, D, et al.
Publicado: (2011)

Clinical severity and local inflammatory responses in animal models of sepsis
por: Saeed, S, et al.
Publicado: (2010)

Atorvastatin and simvastatin protects cognitive impairment in an animal model of sepsis
por: Alexandre, Pedro CB, et al.
Publicado: (2013)

Insufficient autophagy relates to mitochondrial dysfunction, organ failure and adverse outcome in an animal model of critical illness
por: Gunst, J, et al.
Publicado: (2012)

Arginine metabolism in a small animal model of sepsis and after hemihepatectomy
por: Hoven, B Van der, et al.
Publicado: (2009)

Changes in MIF and thyroxine, in a clinically relevant large animal model of sepsis
por: Miller, E, et al.
Publicado: (2009)

Multiple organ dysfunction syndrome: the scapegoat? Assessment of organ dysfunction between surviving and dying mice in the acute phase of polymicrobial sepsis
por: Osuchowski, M, et al.
Publicado: (2009)

High sensitive troponine T as a biomarker and determinant factor of myocardial dysfunction in sepsis
por: Gonzalez Londoño, J, et al.
Publicado: (2015)

In vivo natural killer and natural killer T-cell depletion affects mortality in a murine pneumococcal pneumonia sepsis model
por: Christaki, E, et al.
Publicado: (2012)

Severe sepsis with multiple organ dysfunctions caused by Pseudomonas aeruginosa in an immunocompetent child
por: Jugulete, G, et al.
Publicado: (2012)

Abdominal organs' microcirculation dysfunction sequence in severe sepsis by SDF microscopy and histology
por: Almeida-Filho, J, et al.
Publicado: (2012)

Early administration of low dose norepinephrine for the prevention of organ dysfunctions in patients with sepsis
por: Arslantas, MK, et al.
Publicado: (2015)

Thrombin-activatable fibrinolysis inhibitor and organ dysfunction in disseminated intravascular coagulation associated with sepsis
por: Hayakawa, M, et al.
Publicado: (2011)

Severe protein C deficiency association with organ dysfunction and mortality in patients with severe sepsis
por: Vail, M, et al.
Publicado: (2007)

An integrated epidemiological and neural net model of the warfarin effect in managed care patients
por: Jacobs, David M, et al.
Publicado: (2017)

Use of levosimendan in myocardial dysfunction due to sepsis
por: Vaitsis, J, et al.
Publicado: (2009)

Endocan (endothelial cell-specific molecule-1) as a pertinent biomarker of endothelial dysfunction in sepsis
por: Parmentier, E, et al.
Publicado: (2010)

Increased leukocyte oxidative metabolism in severe sepsis and septic shock correlates with organ dysfunction and mortality
por: Martins, P, et al.
Publicado: (2006)

Argatroban for heparin-induced thrombocytopenia therapy in ICU patients with sepsis or multiple organ dysfunction syndrome
por: Saugel, B, et al.
Publicado: (2009)

Association between elastic and muscular artery stiffness and organ dysfunction in patients with early severe sepsis
por: Kazūne, S, et al.
Publicado: (2015)

Self-organized criticality in a model for developing neural networks
por: van den Akker, Benjamin, et al.
Publicado: (2011)

Effect of protective ventilation on organ-specific cytokine production in an experimental postoperative sepsis model
por: Sperber, J, et al.
Publicado: (2013)

System biology of multiple organ dysfunction: formation of a ceramide-enriched macro-domain in SIRS/sepsis
por: Suckert, I, et al.
Publicado: (2010)

Modelling immune responses in sepsis
por: Grealy, R, et al.
Publicado: (2012)

Biomarkers of sepsis in burn patients
por: Oueslati, H, et al.
Publicado: (2010)

Microalbuminuria: a biomarker of sepsis
por: Basu, S, et al.
Publicado: (2009)

Respiratory organ dysfunction: a leading risk factor for hospital mortality in patients with severe sepsis or septic shock
por: Yang, H, et al.
Publicado: (2008)

Involvement of thrombopoietin in the development of organ injury in a mouse model of cecal ligation and puncture-induced sepsis
por: Greco, E, et al.
Publicado: (2012)

Influence of severity of illness on the effects of eritoran tetrasodium (E5564), a TLR4 antagonist, in patients with severe sepsis
por: Opal, SM, et al.
Publicado: (2009)

Antibacterial therapy in ovine model of sepsis
por: Nakano, Y, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_n0fh258lerf5v0h8jgn7h55sqc